CoChat

Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes

Open access

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Minimal evidence supports the efficacy of flash monitoring in lowering HbA 1c . We sought to assess the impact of introducing flash monitoring in our centre. We undertook a prospective observational study to assess change in HbA 1c in 900 individuals with type 1 diabetes following flash monitoring (comparator group of 518 with no flash monitoring). Secondary outcomes included changes in hypoglycaemia, quality of life, flash monitoring data and hospital admissions. Those with baseline HbA 1c ≥58 mmol/mol (7.5%) achieved a median −7 mmol/mol (interquartile range [IQR] −13 to −1) (0.6% [−1.2 to −0.1]%) change in HbA 1c ( p < 0.001). The percentage achieving HbA 1c <58 mmol/mol rose from 34.2% to 50.9% ( p < 0.001). Median follow-up was 245 days (IQR 182 to 330). Individuals not using flash monitoring experienced no change in HbA 1c across a similar timescale ( p = 0.508). Higher HbA 1c ( p < 0.001), younger age at diagnosis ( p = 0.003) and lower social deprivation ( p = 0.024) were independently associated with an HbA 1c fall of ≥5 mmol/mol (0.5%). More symptomatic (OR 1.9, p < 0.001) and asymptomatic (OR 1.4, p < 0.001) hypoglycaemia was reported after flash monitoring. Following flash monitoring, regimen-related and emotional components of the diabetes distress scale improved although the proportion with elevated anxiety (OR 1.2, p = 0.028) and depression (OR 2.0, p < 0.001) scores increased. Blood glucose test strip use fell from 3.8 to 0.6 per day ( p < 0.001). Diabetic ketoacidosis admissions fell significantly following flash monitoring ( p = 0.043). Flash monitoring is associated with significant improvements in HbA 1c and fewer diabetic ketoacidosis admissions. Higher rates of hypoglycaemia may relate to greater recognition of hitherto unrecognised events. Impact upon quality of life parameters was mixed but overall treatment satisfaction was overwhelmingly positive.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-019-4894-1

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Relationship between baseline HbA1c and subsequent change in HbA1c following flash monitoring. The grey shading indicates the 95% CI for the regression line. Spearman’s r −0.479, p<0.001
Fig. 1 Relationship between baseline HbA1c and subsequent change in HbA1c following flash monitoring. The grey shading indicates the 95% CI for the regression line. Spearman’s r −0.479, p<0.001CC BY · PubMed Central
Fig. 2 Change in HbA1c category pre- and post-flash monitor use; p<0.001, McNemar test for change, in both the <58 mmol/mol (7.5%) and the >75 mmol/mol (9.0%) categories. FM, flash monitoring
Fig. 2 Change in HbA1c category pre- and post-flash monitor use; p<0.001, McNemar test for change, in both the <58 mmol/mol (7.5%) and the >75 mmol/mol (9.0%) categories. FM, flash monitoringCC BY · PubMed Central
Fig. 3 Effect of exposure to flash monitoring on HbA1c trajectory; p<0.001 for mixed effects model assessing interaction of time and flash monitoring category on log-transformed HbA1c. Wilcoxon signed-rank comparison between 2016 and 2018: No FM, p=0.508; NHS FM after Mar 2018, p=0.008; NHS FM Feb/Mar 2018, p<0.001; Previous self-funded and NHS FM Feb/Mar 2018, p<0.001. FM, flash monitoring
Fig. 3 Effect of exposure to flash monitoring on HbA1c trajectory; p<0.001 for mixed effects model assessing interaction of time and flash monitoring category on log-transformed HbA1c. Wilcoxon signed-rank comparison between 2016 and 2018: No FM, p=0.508; NHS FM after Mar 2018, p=0.008; NHS FM Feb/Mar 2018, p<0.001; Previous self-funded and NHS FM Feb/Mar 2018, p<0.001. FM, flash monitoringCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 170

Metadata

Authors
Tyndall, V., Stimson, R. H., Zammitt, N. N., Ritchie, S. A., McKnight, J. A., Dover, A. R., & Gibb, F. W.
Affiliations
  • Western General Hospital (GB)
  • Edinburgh Royal Infirmary (GB)
Corresponding author
Gibb, Fraser W.
Venue
Diabetologia
Published
2019-06-09
Volume
62
Issue
8
Pages
1349-1356
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2950215271
Cited by
165
References
24
Citations by year
2026: 3 · 2025: 7 · 2024: 20 · 2023: 18 · 2022: 29 · 2021: 50 · 2020: 32 · 2019: 4
FWCI
23.33
Type
journal article
Language
en
Open access
Licence
Locations
  • Diabetologia (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
Funders
University of Edinburgh
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
flash glucose monitoring, type 1 diabetes, HbA1c, glycemic control, hypoglycemia, diabetic ketoacidosis, diabetes distress, depression, anxiety, blood glucose test strips, hospitalization, social deprivation, age at diagnosis, HbA1c targets, diabetes self-management, quality of life
MeSH terms
Adult, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Male, Middle Aged, Patient Admission, Prospective Studies, Quality of Life, Surveys and Questionnaires, Research Design, Blood Glucose Self-Monitoring, Diabetic Ketoacidosis, Treatment Outcome, Patient Satisfaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes. https://app.cochat.ai/papers/10.1007/s00125-019-4894-1
The paper
Tyndall, V., Stimson, R. H., Zammitt, N. N., Ritchie, S. A., McKnight, J. A., Dover, A. R., & Gibb, F. W. (2019). Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes. Diabetologia. https://doi.org/10.1007/s00125-019-4894-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.